Department of Otolaryngology-Head and Neck Surgery, National University Hospital, 1E Kent Ridge Road, Singapore, 119228, Singapore.
Division of Interventional Radiology, Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore.
Eur Arch Otorhinolaryngol. 2022 Dec;279(12):5851-5858. doi: 10.1007/s00405-022-07491-8. Epub 2022 Jul 6.
To review the effectiveness and safety of embolisation in managing haemorrhage from the external carotid artery (ECA) system in radiated nasopharyngeal carcinoma (NPC) patients.
Radiated NPC patients who presented with severe oronasal bleeding and underwent digital subtraction angiography that excluded blowouts from the internal carotid artery from 2011 to 2021 were reviewed. Those who subsequently underwent embolisation of the ECA system were analysed for technical success rate, post-embolisation re-bleeding rate and complications.
Seventeen embolisations were performed in fifteen patients during the 10-year period. The technical success rate was 100%, however the early haemostatic rate (no re-bleed within 7 days of embolisation) was 70.6% (12/17) and the overall long-term haemostatic rate was 58.8% (10/17). The re-bleed rates of targeted and empiric embolisations were 33.3% (3/9) and 50.0% (4/8), respectively. The re-bleed rates with liquid agents, coils and particles were 0% (0/7), 33.3% (1/3) and 85.7% (6/7), respectively. Amongst the embolisations utilising liquid agents, 71.4% (5/7) were targeted, distal embolisations. All re-bleeds underwent surgical ligation or repeat embolisation; half of them further experienced recurrent bleeding. There were no significant complications with embolisation.
Although embolisation of the ECA system in NPC has a high technical success rate and is safe, re-bleeding appears to be common. Targeted, distal embolisation with liquid embolics appear to have good haemostatic effect. Clinicians should be aware that patients may need repeated procedures to secure haemostasis.
回顾栓塞治疗放射性鼻咽癌(NPC)患者颈外动脉(ECA)系统出血的有效性和安全性。
回顾性分析 2011 年至 2021 年间因严重口鼻出血而行数字减影血管造影(DSA)检查且排除颈内动脉爆裂的放射性 NPC 患者。对随后行 ECA 系统栓塞的患者进行技术成功率、栓塞后再出血率和并发症分析。
10 年间共对 15 例患者的 17 次栓塞进行了分析。技术成功率为 100%,但早期止血率(栓塞后 7 天内无再出血)为 70.6%(12/17),总体长期止血率为 58.8%(10/17)。靶向和经验性栓塞的再出血率分别为 33.3%(3/9)和 50.0%(4/8)。液体剂、线圈和颗粒的再出血率分别为 0%(0/7)、33.3%(1/3)和 85.7%(6/7)。在使用液体剂的栓塞中,71.4%(5/7)为靶向、远端栓塞。所有再出血患者均行手术结扎或重复栓塞治疗;其中一半进一步发生反复出血。栓塞无明显并发症。
尽管 ECA 系统栓塞治疗 NPC 具有较高的技术成功率且安全,但再出血似乎很常见。靶向、远端使用液体栓塞剂可能具有良好的止血效果。临床医生应注意,患者可能需要重复治疗才能止血。